Lab Test May Detect Parkinson’s Disease Even Before Symptoms Appear

Everyday Health, April 17, 2023

In a first for Parkinson’s research, a large new study confirmed that a laboratory test analyzing brain and spinal cord fluid for clumps of a protein called alpha-synuclein can accurately detect Parkinson’s disease, even in people without symptoms such as tremor and slowed or limited movement.

Published in the May 2023 edition of the Lancet Neurology, the results showed that the lab test was able to identify abnormal protein accumulations in 88 percent of all participants with Parkinson’s disease…READ MORE

Please Note: Important Billing Info

To improve patient access to the SYNTap® Biomarker CSF Test, Amprion offers the following billing options:

  • List price of $1500, with courtesy billing for both Medicare and private insurance.
  • An affordable self-pay price of $995 (patients may qualify for financial assistance and/or interest-free payment options).
  • Prices are effective as of January 1, 2024, and are subject to change.

Please note: Amprion is a Medicare participating provider, however, the SYNTap test does not currently have Medicare coverage determination. Also, Amprion is not yet in network with most insurers.

The SYNTap Biomarker CSF Test has been issued a dedicated CPT® PLA code to be used when billing: 0393U.

For additional information, please visit our billing page.